These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 27787359)
1. Clinical effect of DAPK promoter methylation in gastric cancer: A systematic meta-analysis. Jia W; Yu T; Cao X; An Q; Yang H Medicine (Baltimore); 2016 Oct; 95(43):e5040. PubMed ID: 27787359 [TBL] [Abstract][Full Text] [Related]
2. Influence of HRH2 promoter polymorphism on aberrant DNA methylation of DAPK and CDH1 in the gastric epithelium. Nomura T; Tahara T; Shiroeda H; Minato T; Matsue Y; Hayashi R; Matsunaga K; Otsuka T; Nakamura M; Toshikuni N; Shibata T; Arisawa T BMC Gastroenterol; 2013 Jan; 13():1. PubMed ID: 23280118 [TBL] [Abstract][Full Text] [Related]
3. Death-associated protein kinase promoter methylation correlates with clinicopathological and prognostic features in nonsmall cell lung cancer patients: A cohort study. Yang XY; Zhang J; Yu XL; Zheng GF; Zhao F; Jia XJ J Cancer Res Ther; 2018; 14(Supplement):S65-S71. PubMed ID: 29578152 [TBL] [Abstract][Full Text] [Related]
4. DAPK promoter methylation status correlates with tumor metastasis and poor prognosis in patients with non-small cell lung cancer. Zhang J; Yu XL; Zheng GF; Zhao F Cancer Biomark; 2015; 15(5):609-17. PubMed ID: 26406950 [TBL] [Abstract][Full Text] [Related]
5. Epigenetic regulation of death-associated protein kinase expression in primary gastric cancers from Chinese patients. Ye M; Li D; Zhou F; Guo Q; Xia B Eur J Cancer Prev; 2012 May; 21(3):241-6. PubMed ID: 21979297 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of DAPK promoter hypermethylation in lung cancer: a meta-analysis. Li Y; Zhu M; Zhang X; Cheng D; Ma X Drug Des Devel Ther; 2015; 9():1785-96. PubMed ID: 25848215 [TBL] [Abstract][Full Text] [Related]
7. Association between promoter methylation of DAPK gene and HNSCC: A meta-analysis. Cai F; Xiao X; Niu X; Zhong Y PLoS One; 2017; 12(3):e0173194. PubMed ID: 28249042 [TBL] [Abstract][Full Text] [Related]
8. DAPK Promoter Methylation and Bladder Cancer Risk: A Systematic Review and Meta-Analysis. Dai L; Ma C; Zhang Z; Zeng S; Liu A; Tang S; Ren Q; Sun Y; Xu C PLoS One; 2016; 11(12):e0167228. PubMed ID: 27907054 [TBL] [Abstract][Full Text] [Related]
9. Methylated TMS1 and DAPK genes predict prognosis and response to chemotherapy in gastric cancer. Kato K; Iida S; Uetake H; Takagi Y; Yamashita T; Inokuchi M; Yamada H; Kojima K; Sugihara K Int J Cancer; 2008 Feb; 122(3):603-8. PubMed ID: 17943730 [TBL] [Abstract][Full Text] [Related]
10. Promoter methylation of DAPK gene may contribute to the pathogenesis of nonsmall cell lung cancer: a meta-analysis. Li FF; Yang Y; Wang XL; Hong YY; Wang NF; Chen ZD Tumour Biol; 2014 Jun; 35(6):6011-20. PubMed ID: 24659425 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of DAPK and RASSF1A promoter hypermethylation in non-small cell lung cancer (NSCLC). Niklinska W; Naumnik W; Sulewska A; Kozłowski M; Pankiewicz W; Milewski R Folia Histochem Cytobiol; 2009; 47(2):275-80. PubMed ID: 19926549 [TBL] [Abstract][Full Text] [Related]
12. Promoter hypermethylation of RARβ2, DAPK, hMLH1, p14, and p15 is associated with progression of breast cancer: A PRISMA-compliant meta-analysis. Qi M; Xiong X Medicine (Baltimore); 2018 Dec; 97(51):e13666. PubMed ID: 30572486 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathological significance of DAPK gene promoter hypermethylation in non-small cell lung cancer: A meta-analysis. Chen Z; Fan Y; Liu X; Shang X; Qi K; Zhang S Int J Biol Markers; 2022 Mar; 37(1):47-57. PubMed ID: 34935548 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of DAPK promoter methylation in lymphoma: A meta-analysis. Wang H; Zhou LY; Guan ZB; Zeng WB; Zhou LL; Liu YN; Pan XY PLoS One; 2019; 14(1):e0210943. PubMed ID: 30682070 [TBL] [Abstract][Full Text] [Related]
15. Gene methylation profile of gastric cancerous tissue according to tumor site in the stomach. Kupcinskaite-Noreikiene R; Ugenskiene R; Noreika A; Rudzianskas V; Gedminaite J; Skieceviciene J; Juozaityte E BMC Cancer; 2016 Jan; 16():40. PubMed ID: 26810771 [TBL] [Abstract][Full Text] [Related]
16. CpG island methylation of the MLH1, MGMT, DAPK, and CASP8 genes in cancerous and adjacent noncancerous stomach tissues. Kupčinskaitė-Noreikienė R; Skiecevičienė J; Jonaitis L; Ugenskienė R; Kupčinskas J; Markelis R; Baltrėnas V; Sakavičius L; Semakina I; Grižas S; Juozaitytė E Medicina (Kaunas); 2013; 49(8):361-6. PubMed ID: 24509146 [TBL] [Abstract][Full Text] [Related]
17. Promoter methylation of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers. Liu Y; Gao W; Siegfried JM; Weissfeld JL; Luketich JD; Keohavong P BMC Cancer; 2007 May; 7():74. PubMed ID: 17477876 [TBL] [Abstract][Full Text] [Related]
18. Effect of methylation-associated silencing of the death-associated protein kinase gene on nasopharyngeal carcinoma. Kong WJ; Zhang S; Guo CK; Wang YJ; Chen X; Zhang SL; Zhang D; Liu Z; Kong W Anticancer Drugs; 2006 Mar; 17(3):251-9. PubMed ID: 16520653 [TBL] [Abstract][Full Text] [Related]
19. An inverse correlation between Interleukin-6 and select gene promoter methylation in patients with gastric cancer. Tang LP; Cho CH; Hui WM; Huang C; Chu KM; Xia HH; Lam SK; Rashid A; Wong BC; Chan AO Digestion; 2006; 74(2):85-90. PubMed ID: 17139167 [TBL] [Abstract][Full Text] [Related]
20. The Correlation of MGMT Promoter Methylation and Clinicopathological Features in Gastric Cancer: A Systematic Review and Meta-Analysis. Ding Y; Yang Q; Wang B; Ye G; Tong X PLoS One; 2016; 11(11):e0165509. PubMed ID: 27824946 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]